# Nimbus Therapeutics: Research, Boston, United States

> Nimbus Therapeutics: Nimbus Therapeutics is a clinical-stage biotechnology company based in Boston, Massachusetts, founded in 2009.

Source: https://millionrounds.com/startup/nimbus-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# Nimbus Therapeutics

Nimbus Therapeutics is a clinical-stage biotechnology company based in Boston, Massachusetts, founded in 2009.

Funding reported Last round: Private equity

Research Boston, United States

Company summary

- **Founded:** 2009 17 years old
- **Team:** 100 51 to 200 people
- **Funding reported:** $637M in dollars
- **Last round:** Private equity Sept 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Nimbus Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Nimbus Therapeutics

Nimbus Therapeutics is a clinical-stage biotechnology company based in Boston, Massachusetts, founded in 2009.

The company specializes in structure-based drug discovery, focusing on developing innovative small molecule medicines for challenging therapeutic areas, particularly those involving difficult-to-drug proteins linked to various human diseases. Nimbus employs advanced computational technologies and machine learning to enhance drug design and discovery processes. The company offers a range of drug discovery capabilities, including structure-based drug discovery, computational drug design, and machine learning-based predictive modeling. Nimbus is actively developing a pipeline of small molecule therapeutics targeting oncology, immunology, and metabolic diseases. Its notable projects include a clinical-stage HPK1 inhibitor for cancer treatment and a diverse preclinical portfolio addressing cancer, autoimmune conditions, and metabolic disorders. Nimbus collaborates with major pharmaceutical companies like Roche and Gilead Sciences to advance its drug development efforts.

## What company datasets say Nimbus Therapeutics raised

Funding, as reported

Reported in all **$637M** in dollars

Rounds **9**

Last round **Private equity**

Last round size **$210M**

Last round date **Sept 2023**

Investors listed **19**

## Founders and team

From Nimbus Therapeutics's own website: 3 on the team.

- **Value Creation** Chief Executive Officer
- **Steve Simmons** Vice President, Information Technology
- **Supported By A Stellar** Board Of Directors

## The company, in detail

What they build

Known for

health care metabolism allosteric inhibitors strategic partnerships msi-h tumor targeting biotechnology research tyk2 inhibitors therapeutic candidates molecular modeling structure-based drug design translational research small molecule therapeutics machine learning predictions enterprises autoimmune disease drugs target selectivity optimization

Built with from their website

Google Maps Adobe WordPress.org Ironclad Atlassian Clarity SDM Viewport Meta Mimecast WP Engine Conga Contracts

+8 more

Oracle Email Server Oracle SPF Celigo OpenAI Apple Business Manager Google Cloud Hosting AI NetSuite

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 2834
- **Region:** Massachusetts
- **Part of:** Gilead Sciences
- **Revenue:** $21M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/nimbus-therapeutics)

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put Nimbus Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)